# Efficacy and Safety of Probiotics in Neonatal Hyperbilirubinemia

> **NCT03266913** · PHASE3 · UNKNOWN · sponsor: **Hormozgan University of Medical Sciences** · enrollment: 126 (estimated)

## Conditions studied

- Hyperbilirubinemia, Neonatal

## Interventions

- **DRUG:** Probiotic

## Key facts

- **NCT ID:** NCT03266913
- **Lead sponsor:** Hormozgan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-01
- **Primary completion:** 2017-10-01
- **Final completion:** 2017-11-01
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2017-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03266913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03266913, "Efficacy and Safety of Probiotics in Neonatal Hyperbilirubinemia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03266913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*